We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Hydrogen Inhalation Protects Brain during Circulatory Arrest

By HospiMedica International staff writers
Posted on 15 May 2019
Print article
A new study suggests that adding 2.4% inhaled hydrogen (H2) to the inspiratory gases administered during cardiopulmonary bypass diminishes potential neurologic injury.

Researchers at Boston Children’s Hospital (BCH; MA, USA) and Harvard Medical School (HMS; Boston, MA, USA) conducted a study in neonatal swine that were cannulated to extracorporeal membrane oxygenation (ECMO; cardiopulmonary bypass) and then exposed to prolonged mildly hypothermic circulatory arrest (75 minutes at 25°C). The swine were then randomized to inhalation of inspiratory gas mixtures (with or without inhaled H2 gas) for 24 hours during and following an ischemic injury.

The results revealed that the H2-treated neonatal swine exhibited significantly decreased neurologic and renal injury compared to controls, as quantified by clinical examination, magnetic resonance imaging (MRI)-graded volume of injury, serology, and histopathology. The researchers suggest that in the future, inhaled H2 could be used to diminish the sequelae of ischemia that occurs in congenital heart surgery, cardiac arrest, extracorporeal life-support events, acute myocardial infarction (MI), stroke, and organ transplantation. The study was published on April 29, 2019, in JACC: Basic to Translational Medicine.

"We've gotten better at resuscitating patients and getting the heart to start beating, and even some emergency departments are putting patients onto ECMO; but during that time, the brain may be deprived of oxygen,” said senior author cardiologist John Kheir, MD, of BCH. “During the reperfusion process, the cell mitochondria overreact and end up using oxygen to injure themselves. What we want to do is create an ancillary therapy that is cheap and easy to do that can mitigate injury in survivors.”

ECMO is a form of veno-venous extracorporeal life support, an emerging therapy designed to infuse oxygen directly into the bloodstream using an oxygenator that acts as an artificial lung, optimizing gas exchange and reducing stress on the right side of the heart. When infants are placed on ECMO, the interrupted blood flow causes temporary hypoxia; the brain, a heavy oxygen user, is most susceptible to oxygen deprivation. But the most damage occurs during reperfusion, as oxygen is reintroduced. The sudden influx causes toxic reactive oxygen species (ROS), which damage DNA and cell membranes. H2 can buffer the effects of the ROS.

Related Links:
Boston Children’s Hospital
Harvard Medical School

 


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
EEG System
BRAIN QUICK

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.